Biliary tract cancers are rare but fatal malignancies, with increasing incidence in Shanghai, China. Gallstones, the primary risk factor for biliary tract cancer, typically result from oversaturation of cholesterol in bile. We examined the association of five variants in three lipid metabolism-related genes (CETP, ABCG8 and LRPAP1) and biliary tract cancers and stones in a populationbased case-control study in Shanghai, China. We included 439 biliary tract cancer cases (253 gallbladder, 133 extrahepatic bile duct and 53 ampulla of Vater cancer cases), 429 biliary stone cases and 447 population controls. Carriers of the CG genotype of ABCG8 rs11887534 had higher risk of biliary stones [odds ratio (OR) 5 2.3, 95% confidence interval (CI) 0.82-6.5), gallbladder cancer (OR 5 4.3, 95% CI 1.7-10.4) and bile duct cancer (OR 5 1.94, 95% CI 0.64-5.91), compared with carriers of the GG genotype. Analysis stratified by gender showed both male and female carriers of CG rs11887534 had higher risks of biliary stones and gallbladder cancer, although the association was statistically significant only for women and gallbladder cancer (OR 5 6.3, 95% CI 1.86-22.3). Carriers of the ABCG8 haplotype C-C (rs4148217-rs11887534) had a 4.16-fold (95% CI 1.71-10.1) risk of gallbladder cancer compared with those carrying the C-G haplotype. Our findings suggest that ABCG8 rs11887534, identified as a gallstone risk single-nucleotide polymorphism by whole genome scan, is also associated with an increased risk of biliary tract cancer.
Introduction
Biliary tract cancers include cancers of the gallbladder, extrahepatic bile duct and ampulla of Vater. They are rare but highly fatal malignancies with poor survival (1) . Gallstones are the most important risk factor for biliary tract cancers, especially those of the gallbladder. In a previous report, we showed that gallstones are associated with a 24-fold risk of gallbladder cancer in Shanghai (2) . With increasing westernization of diet in China, most gallstone cases diagnosed in Shanghai in the recent past are cholesterol in origin, which are related to dyslipidemia and oversaturation of cholesterol in bile (3) .
High serum lipid levels are a risk factor for gallstones and have been associated with biliary tract cancers (4) . Serum lipid levels are affected by both genetic and lifestyle factors (5, 6) . Several genes in the cholesterol metabolism pathway play an important role in lipid biosynthesis, metabolism and transport, which in turn can affect the pathogenesis of gallstones and biliary tract cancer. For example, the ABCG5/BCG8 gene, identified to be associated with gallstones by a genome-wide association study (GWAS) (7) , is expressed exclusively in the liver and intestine, can form heterodimers to regulate the efflux of sterols into intestinal lumen and control the hepatic secretion of sterols into the bile (8, 9) . Similarly, cholesteryl ester transfer protein (CETP) is an enzyme involved in facilitating the removal of excess cholesterol from the body via low-density lipoprotein (LDL) receptor-mediated uptake in the liver (10) . LRPAP1 is involved with trafficking of certain members of the LDL receptor family including LDL receptor-related proteins (LRP1and LRP2) (11) .
In an earlier report, we showed that variants in the lipid metabolism genes APOE (rs440446), APOB (rs520354) and LDLR (rs1003723) were associated with biliary tract cancers and stones (12) . To further clarify the effect of lipid metabolizing genes on biliary tract cancer and stone risks, we investigate the associations of variants in ABCG8 (rs4148217, rs11887534), CETP (rs708272, rs1800775) and LRPAP1 (rs11267919) with the risk of biliary tract cancer and stones in a population-based case-control study in Shanghai, China.
Materials and methods

Study subjects
Details of the study methods have been reported elsewhere (2, 13, 14) . Briefly, cancer cases were identified by a rapid reporting system established by the Shanghai Cancer Institute and 42 collaborating hospitals in Shanghai. Through this system, we identified .95% of all incident biliary tract cancer cases (International Classification of Diseases, Ninth Edition code 156) diagnosed among Shanghai residents between June 1997 and May 2001. A total of 439 incident biliary tract cancer cases (253 gallbladder, 133 extrahepatic bile duct and 53 ampulla of Vater cases), between 36 and 75 years, were included in this study. To evaluate the risk of biliary stones independently of biliary tract cancer, 430 patients with biliary stones without a history of cancer were included and were frequency matched to the cancer cases on age (5 years groups), gender and diagnosing hospital. Population controls, without a history of biliary tract cancer, were randomly selected from the Shanghai Resident Registry, which includes records for $6 million Shanghai residents. We included a total of 443 population controls who were frequency matched to cancer cases on age (5 years groups) and gender.
Case confirmation
Biliary tract cancer and biliary stone diagnoses were confirmed by a panel of clinicians, ultrasonographers and pathologists. Seventy percent of biliary tract cancer cases were confirmed by histopathologic assessment, whereas the remaining 30% of cases, for whom we did not have histopathologic material, were confirmed using medical records, surgical reports and imaging data, including magnetic resonance imaging, endoscopic retrograde cholangiopancreatography or computed tomography. Biliary stone cases were confirmed by review of abdominal ultrasound, endoscopic retrograde cholangiopancreatography films, medical records and surgical records or by pathologic material for those who underwent a cholecystectomy.
Gallstone assessment
Gallstone status was assessed in nearly all biliary tract cancer cases and population controls. Among cancer cases, gallstones were identified by selfreported history, surgical reports or imaging results from magnetic resonance imaging, endoscopic retrograde cholangiopancreatography, computed tomography or ultrasound. Among population controls, gallstones were identified by self-reported history or by abdominal ultrasound for those who gave consent for the procedure (85% of all population controls).
Interview
Information on demographic characteristics, medical histories and lifestyle factors was obtained through in-person interviews conducted by trained interviewers using a structured questionnaire. Cases were interviewed within 3 weeks of diagnosis. Weight and height were measured at the time of interview. The response rate for interviews was .95% among cases and 82% among controls. Five percent of the study subjects were randomly selected for re-interview 3 months after the initial interview to assess the reproducibility of responses. The concordance of responses to key questions between the original and follow-up interviews was .90%.
Genotyping
Three candidate genes were selected based on their role in cholesterol metabolism and potential effects on biliary disease pathogenesis. Single-nucleotide polymorphisms (SNPs) were selected based on their putative functional significance (ABCG8 rs4148217, CETP rs708272 and rs1800775 and LRPAP1 rs11267919) or by association with gallstone risk from whole genome scan (ABCG8 rs11887534). Overnight fasting blood samples were collected from all subjects who gave consent (.80%). Genomic DNA was extracted from buffy coat using Promega DNA Extraction Kit. Genotyping of ABCG8 (rs4148217, rs11887534) and CETP (rs708272, rs1800775) were performed by the TaqMan assay, using the ABI PRISM 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA), in 384-well format, with dual fluorescent reporter probes VIC and FAM. Genotyping of LRPAP1 rs11267919, an insertion/deletion variation, was conducted by polymerase chain reaction and visualized by agarose gel electrophoresis. The genotyping failure rate among all samples was ,1.5%. The quality and potential misclassification of the genotyping results were assessed by evaluating 5% of duplicate DNA samples from four quality-control subjects (63 total samples) that were randomly placed within the same reaction plates used for the study subjects. The replicates were 100% concordant.
Statistical analysis
The final analysis included subjects who completed the interview and for whom we had genotyping results, which totaled 439 incident biliary tract cancer cases (253 gallbladder, 133 extrahepatic bile duct and 53 ampulla of Vater cases), 430 biliary stone cases and 447 healthy controls. To make the appropriate case-control comparisons, for all analyses, gallbladder cancer cases were compared with controls without a history of cholecystectomy (n 5 422), bile duct cancer cases and ampulla of Vater cancer cases were compared with all controls (n 5 447) and biliary stone cases were compared with controls without biliary stones (n 5 341). Distributions of selected characteristics, including gender, age, education, cigarette smoking, alcohol drinking, gallstone status (among cancer cases), hypertension, diabetes, body mass index (BMI) and waist to hip ratio (WHR), were evaluated among cases and controls; characteristics with statistically significant different distributions between cases and controls (Fisher's exact P , 0.05) were examined for their associations with SNPs among controls.
The associations between SNPs and biliary tract cancer and stone risk were estimated by odds ratios (OR) and 95% confidence intervals (CI) using unconditional logistic regression. Risk estimates were calculated for the heterozygous and homozygous variant genotypes relative to the common homozygous genotype (codominant model), as well as for the presence and absence of the variant allele (dominant model), using indicator variables in the regression model. An initial model was adjusted for age, and additional models were further adjusted for gender, education, cigarette smoking, alcohol drinking, gallstone status (cancer risk only), hypertension, diabetes, BMI and WHR. Associations between SNPs and biliary diseases were also evaluated separately by gender and biliary stone status, and statistical interaction was evaluated using the likelihood ratio test.
Hardy-Weinberg equilibrium for genotypic distribution and linkage disequilibrium between loci in ABCG8 and CETP genes were assessed by HaploView version 4.0 (15) . Associations between haplotypes (.1% frequency) and the risks of biliary tract stones and cancer were evaluated by computing OR and 95% CI, using HAPSTAT, assuming an additive model, and using the most common haplotype as the referent category (16) . Global differences in haplotype frequencies between cases and controls were assessed for each gene using the Score test in HAPSTAT. A population-based case-control study in Shanghai, China
Results
Selected characteristics of the study subjects are shown in Table I . The frequency of selected characteristics did not differ considerably between the three subgroups of controls (all controls, controls without cholecystectomy and controls without biliary stones). Biliary stone cases were more probably to be younger, have a higher WHR but less probably to drink alcohol compared with controls without stones. Gallbladder cancer cases were more probably to be female (73.1%), illiterate, have gallstone (84.6%), have higher BMI and WHR than the controls with gallbladder. Bile duct cancer and ampulla of Vater cancer cases were more common in men, more probably to smoke cigarettes, have gallstone, have higher WHR but less probably to have hypertension. Furthermore, bile duct cancer cases were more probably to drink alcohol, and ampulla of Vater cancer cases were more probably to have a moderate BMI (18.5-22.9 kg/m 2 ). The associations of the ABCG8, CETP and LRPAP1 variants with biliary stones and cancers are presented in Table II . The genotype distributions of these five variants showed no deviation from the expected Hardy-Weinberg equilibrium among controls (P . 0.1). Of these SNPs, carriers of the GC genotype of ABCG8 rs11887534 had higher risk of biliary stones (OR 5 2.3, 95% CI 0.82-6.5), gallbladder cancer (OR 5 4.3, 95% CI 1.7-10.4) and bile duct cancer (OR 5 1.9, 95% CI 0.64-5.91) compared with those carrying the GG genotype. The association for gallbladder cancer remained statistically significant after further adjustment for gender, education, BMI and WHR (OR 5 4.9, 95% CI, 1.9-13.0) but was no longer significant after adjustment for gallstone status (OR 5 2.6, 95% CI, 0.80-8.5). Analysis stratified by gender showed that both male and female carriers of CG rs11887534 also had higher risks for biliary stones and gallbladder cancer, although the association was statistically significant only for women and gallbladder cancer (OR 5 6.3, 95% CI 1.86-22.3). We were not able to evaluate the effects of rs11887534 by biliary stone status due to the small number of subjects in these strata. None of the other SNPs examined were associated with biliary disease.
The two CETP SNPs, rs708272 and rs1800775, are in strong linkage disequilibrium (D# 5 1.0), whereas the linkage disequilibrium between ABCG8 rs4148217 and rs11887534 is modest (D# 5 0.56) (17) . Table III lists the associations between ABCG8 and CETP haplotypes and biliary stones and cancers. Carriers of the ABCG8 (rs4148217-rs11887534) C-C haplotype had excess risks of biliary stones (OR 5 1.9, 95% CI, 0.83-4.32), gallbladder cancer (OR 5 4.16, 95% CI, 1.71-10.1) and bile duct cancer (OR 5 1.87, 95% CI, 0.62-5.65) relative to carries of the C-G haplotype. The CETP haplotypes were not significantly associated with biliary stones or cancers. These haplotype results are consistent with the individual SNP results.
Discussion
In this population-based study in Shanghai, we found that ABCG8 rs11887534, the SNP identified to be associated with risk for gallstones by GWAS, was associated with biliary stones and biliary tract cancers and in particular with gallbladder cancer among women. We also found an association between the ABCG8 haplotype (rs4148217-rs11887534) and gallbladder cancer. These findings suggest that variants in lipid metabolism-related genes play a role in biliary stones and cancers. Our finding of ABCG8 rs11887534 validates results from GWAS and is consistent with previous studies. In a GWAS study in Germany (1385 cases and 1233 controls), the rs11887534 GC carriers had 2.2-fold risk of gallstone disease (7) . A study of monozygotic twins in Sweden also showed that that rs11887534 was significantly associated with the risk of gallstones (OR 5 2.5; 95% CI, 1.33-4.82) (18) . Among Chinese men, ABCG8 has been associated with gallstones in both Taiwan and China (19, 20) . For gallbladder cancer, the rs11887534 variation was found to be associated with a 1.8-fold risk (95% CI, 1.1-2.8), primarily in gallbladder cancer patients with stones (OR 5 1.8; 95% CI, 1.0-3.1) in a study in India (21) . In our study, rs11887534 variant was associated with both gallstones and gallbladder cancer, but we were not able to examine the joint effect of this variant and gallstones on the risk of gallbladder cancer due to small numbers. However, after adjustment for gallstones, the association between ABCG8 variant and gallbladder cancer was no longer significant, suggesting that the association between rs11887534 and gallbladder cancer is mediated by gallstones.
Our findings for ABCG8 rs11887534 are biologically plausible. ABCG8 rs11887534, also called D19H, is a missense variation that causes an amino acid change from an acidic amino acid (aspartic acid) to a basic amino acid (histidine). Although the biological effect of this amino acid change is still unclear, it has been shown that carriers of the rs11887534 variant have lower serum plant sterol levels (sitosterol and lathosterol) and higher cholesterol precursors (cholesterol and lathosterol) levels (22, 23) , suggesting an important role of ABCG8 gene in regulating cholesterol metabolism. This was also observed in a study in Taiwan, where subjects with the rs11887534 GC genotype had a 3-fold risk of high cholesterol than those with the GG genotype (19) . On a cellular level, the ABCG8 protein heterodimerizes with ABCG5 and resides in the cellular membrane where it plays an important role in biliary cholesterol excretion. Mice lacking either ABCG8 or ABCG5 had reduced biliary cholesterol output (24, 25) . Higher hepatic expression of ABCG5/8 was positively correlated with high biliary cholesterol secretion and formation of gallstone in mice (26, 27) . In humans, ABCG5 and/or ABCG8 messenger RNA expression was found to be increased in gallstone patients, which might contribute to excessive biliary cholesterol supersaturation (28) . Also, ABCG5/8 dysfunction has been found to be related to sitosterolemia, hypercholesterolemia, cardiovascular and gallstone diseases (29) (30) (31) . Our data on ABCG8 rs11887534 are consistent with these previous findings.
We did not find an association between CETP variants and biliary tract stones or cancer. In previous studies, CETP variants were associated with gallstones in Finnish and Chinese populations, but not in an Indian population (32) (33) (34) .
Strengths and limitations of our study should be noted. Strengths of our study include the population-based design, thereby minimizing selection bias; detailed review of cancer diagnosis, thereby minimizing disease misclassification and use of good quality and purity of extracted DNA, thereby minimizing misclassification of genotypes. Although our study is the largest to date, the minor allele frequency of ABCG8 rs11887534 in our Chinese population was low (2%), which limits our ability to evaluate specific effects in subgroups, such as the joint effect of ABCG8 and gallstones on gallbladder cancer risk among women. We also cannot rule out chance findings due to low statistical power and multiple comparisons.
In conclusion, our results suggest that ABCG8 (rs4148217, rs11887534) may play a role in biliary tract cancer pathogenesis. However, the relationship between the risk alleles and biliary tract disease need to be validated in a larger population. Furthermore, future studies are needed to determine if any of the risk SNPs are functional and if they directly contribute to biliary tract carcinogenesis and stone formation. A population-based case-control study in Shanghai, China
